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The nature of the rate-limiting step for glucose utilization by the clonal insulin-producing cell line HIT-T 15 
has been investigated. In contrast to the situation in islets of Langerhans, we find that the HIT cell glucose 
metabolism is limited by the rate of entry of glucose into the cell. This is evidenced by the low rate of sugar 
transport and by the marked reduction in the rate of glucose utilization elicited by inhibitors of the glucose 
transporter. As judged by competition with glucose, the HIT cell glucose transporter also transports man- 
nose, 2-deoxyglucose and 3-0-methylglucose but not L-glucose or N-acetylglucosamine. The K,,, for glucose 
of the glucose transporter, measured as the concentration of glucose required for a half-maximal rate of 
glucose utilization, is 4.3 mM, similar to the concentration reported to give half-maximal insulin release. 
Glucose-stimulated insulin release from HIT cells is inhibited by phloretin or cytochalasin B but not by 
mannoheptulose. We conclude that the secretory responses of HIT cells are consistent with the substrate-site 
hypothesis, but that, in contrast to normal B-cells, the glucose sensor which confers concentration-depend- 
ence and specificity to sugar-stimulated insulin release, is the glucose transporter. 
Insulin secretion; Glucose transport; B-cell line; (Pancreatic B-cell) 
1. INTRODUCTION 
In the B-cells of the islets of Langerhans glucose 
transport into the cell is non-rate-limiting [l]; the 
rate-limiting step for sugar metabolism is hexose 
phosphorylation [2]. The high K,,, (8 mM) for 
glucose utilization by the B-cell [1,3] is a conse- 
quence of the presence of a high K,,, glucokinase 
[ 1,4,5]. Since changes in glucose metabolism rates 
are causally related to insulin release [2], the 
glucokinase is regarded as the glucose sensor con- 
ferring concentration-dependence and specificity 
to the insulin secretory response to sugars [2,6]. 
The cloned B-cell line HIT-T15 is an important 
model for studying insulin secretory mechanisms 
because these cells, which can be grown in culture 
in essentially unlimited amounts, retain a secretory 
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response to glucose [7-91. We [9] and others [8] 
have noted, however, that the K,,, for glucose of 
the glucose-stimulated insulin release in HIT cells 
is lower than in normal B-cells: this difference has 
been attributed to slow uptake of the sugar [lo]. If 
glucose entry is indeed rate-limiting in HIT cells 
then it follows that modification of the rate of 
transport of the sugar should produce parallel ef- 
fects on glucose utilization and hence insulin 
release. In other words the glucose-sensor in HIT 
cells would be the glucose transporter. The present 
study provides evidence for this concept. 
2. MATERIALS AND METHODS 
HIT-T15 cells were cultured in RPM1 1640 con- 
taining 10% foetal calf serum and antibiotics as 
described [9]. For measurement of rates of glucose 
utilization and insulin release 5 x 10’ cells were 
seeded in 1 ml medium in 24-well multiwells. After 
culture for 3-6 days, the culture medium was 
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removed and replaced by a Hepes-buffered bicar- 
bonate medium [l l] supplemented with 5 mg/ml 
albumin. After 30-60 min the latter was aspirated 
and replaced with a similar bicarbonate medium 
containing test substances. When glucose utiliza- 
tion was to be measured as the formation of 3Hz0 
from [5-3H]glucose [3] the medium contained 1 &i 
[5-3H]glucose. After 45-90 min at 37°C in an at- 
mosphere of humidified air, samples of the media 
from each well were taken and centrifuged at 4°C 
for 5 min at 500 x g to sediment any free floating 
cells. Aliquots of the supernatant were diluted with 
phosphate buffer containing 2 mg/ml albumin and 
merthiolate and stored frozen until assayed for in- 
sulin by a charcoal-based radioimmunoassay [ 121. 
Further 100 ,J aliquots of the supernatant were 
acidified by the addition of 20 ~1 N. HCl and 
placed in small tubes inside stoppered scintillation 
vials containing 0.5 ml HzO. After equilibration 
overnight at 37”C, the 3H~0 recovered in scintilla- 
tion vials was measured by liquid scintillation spec- 
trometry. 
For measurement of sugar uptake, lo5 cells were 
incubated in 100 ,J Hepes-buffered bicarbonate 
medium containing albumin (5 mg/ml) and either 
3HOH (IO&i/ml), 3-0-[U-‘4C]methylglucose (0.5 
mM; 2-lo&i/ml), [U-‘4C]sucrose (0.5 mM; 2-10 
&i/ml) or [2-3H]glucose (0.5 mM; 2-lo&i/ml). 
After incubation at 37”C, cells were spun through 
100~1 of a mixture of dibutyl- and dinonylphthal- 
ate (3: 1) into 20 ~1 of 6 M urea in a Beckman 
microfuge tube. The tubes were frozen in liquid NZ 
and their tips cut off; tip contents were dissolved 
in 10 ml Opti-fluor (Packard Instruments) for 
measurement of radioactivity by liquid scintilla- 
tion spectrometry using a Packard Tricarb with the 
external standard method for quench correction. 
The water and sugar spaces of the HIT cells were 
calculated after correction for the contamination 
of the cell pellet by the incubation medium, using 
[U-‘4C]sucrose as extracellular space marker. 
3. RESULTS 
The intracellular water space of HIT cells was 
0.81 kO.12 PI/cell (n=6). The uptake of 3-0- 
methylglucose was slow: after 5 min incubation the 
3-0-methylglucose space was only 33% of the in- 
tracellular Hz0 space. After 20 min incubation 
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3-0-methylglucose had attained 76% equilibra- 
tion. [2-3H]Glucose uptake was also slow, averag- 
ing after 5 and 20 min respectively 26 and 54% of 
the intracellular Hz0 space. 
Rates of glucose utilization by HIT cells were 
linear for 2 h and were dependent on the extra- 
cellular glucose concentration over the range 
0.5-20 mM. A double-reciprocal plot was linear 
and indicated a K, for glucose of 4.3 mM (fig.1). 
Table 1 shows the effects of various agents on 
glucose utilization. Mannoheptulose (20 mM) did 
not significantly reduce the rate of glucose utiliza- 
tion at 5 mM glucose. However, glucose utilization 
was severely depressed by the inhibitors of glucose 
transport systems, phloretin (0.18 mM), phloridzin 
(5 mM) and cytochalasin B (50 pg/ml). Glucose 
utilization was also inhibited by caffeine (5 mM) or 
forskolin (1OpM). The effects of lower concentra- 
tions of phloretin and cytochalasin B are shown in 
table 2. As little as 0.1 pg/ml cytochalasin B pro- 
duced significant inhibition of glucose utilization; 
phloretin was effective at 50 but not at 20pM. The 
effects of other sugars on glucose utilization are 
given in table 3. Sugars were tested at a concentra- 
tion of 20 mM in the presence of 1 mM glucose. No 
significant effect was observed with L-glucose or 
N-acetylglucosamine. A small inhibition occurred 
in the presence of galactose, fructose, goldthio- 
glucose or 6-deoxygalactose. Glucose utilization 
was greatly depressed by the simultaneous presence 
of mannose, 3-0-methylglucose or 2-deoxyglucose. 
O- 
l/[Glucose] mM_’ 
Fig. 1. HIT cell glucose utilisation. Rates of glucose 
utilization were measured as the rate of formation of 
‘Hz0 from [5-3H]glucose by HIT cells incubated for 2 h 
at 37°C. Rates were linear over this period. The data are 
plotted as a double-reciprocal plot of the mean values 
for 8 determinations at each glucose concentration. 
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Table 1 Table 3 
Effects of sugars on HIT cell glucose utilization Effects of phloretin, phloridzin, cytochalasin B and 
caffeine on HIT cell glucose utilization 
Agent Concen- Glucose utilization 
tration (nmol/well) 
None - 55.5 f 3.4 (24) 
Phloretin 0.18 mM 19.9 + 1.6 (8)* 
Phloridzin 5 mM 18.8 + 0.6 (4)* 
Cytochalasin B 50 pg/ml 2.3 f 0.1 (4)* 
Caffeine 5mM 36.1 f 1.4 (4)* 
Forskolin 1 mM 16.6 f 1.0 (4)* 
* Significantly different from control P<O.OOl 
HIT cells were incubated with [5-3H]glucose (1 mM) and 
the additions shown for 1 h at 37°C. Glucose utilization 
was measured as the formation of ‘Hz0 as described in 
the text. Data are given as mean k SE for the number 
of observations shown 
Agent (20 mM) Glucose utilization 
(Yo of control) 
The effects of mannoheptulose, cytochalasin B 
and phloretin on insulin secretion are shown in 
table 4. In the presence of 5 mM glucose, insulin 
release was not inhibited by 20 mM mannohep- 
None 100 f 6 (20) 
Mannose 16 + 7 (12)* 
2-Deoxyglucose 13 + 3 (8)* 
3-0-Methylglucose 32 f 5 (4)* 
Galactose 78 -+ 2 (8)* 
6-Deoxygalactose 64 + 2 (8)* 
Fructose 85 + 2 (8)* 
Gold thioglucose 77 + 8 (8)* 
N-Acetylglucosamine 103 f 4 (8) 
L-Glucose 103 rt 4 (8) 
* Significantly less than control (P<O.OOl) 
All sugars are the D-stereoisomer except for L-glucose. 
HIT cells were incubated with [5-3H]glucose (1 mM) and 
the sugars shown (20 mM) for 1 h at 37°C. Glucose 
utilization was measured as the formation of 3Hz0. Data 
are expressed as % of control (no addition) rate in the 
same experiment and are given as mean +- SE for the 
number of observations shown. The mean absolute 
value of glucose utilization in these experiments was 27.7 
nmol/well 
Table 2 
Effects of varying concentrations of phloretin and 
cytochalasin B on HIT cell glucose utilization 
Agent Concen- Glucose utilization 
tration (nmol/well) 
None _ 52.2 + 1.4 (6) 
Phloretin 10pM 54.9 * 3.1 
20 pM 51.5 * 3.1 
50 ,uM 42.5 + 0.9 (3)* 
1OOpM 30.6 k 0.7 * 
200,uM 20.2 * 0.7 * 
Cytochalasin B 0.1 pg/ml 42.0 + 6.3 
0.2 pg/ml 39.7 + 2.0 * 
0.5 /g/ml 23.3 f 2.9 * 
1 ,ug/ml 16.1 + 2.9 * 
5 pg/ml 6.0 + 2.2 * 
10 fig/ml 6.3 + 2.3 * 
* Significantly less than control P<O.OOl 
HIT cells were incubated with [5-3H]glucose (1 mM) and 
the additions shown for 1 h at 37°C. Glucose utilization 
was measured as the formation of 3Hz0 as described in 
the text. Data are given as mean + SE for 4 observations 
except where indicated otherwise 
Table 4 
Effects of phloretin, cytochalasin B and 
monnoheptulose on glucose-stimulated insulin secretion 
by HIT cells 
Agent Concen- Insulin release 
tration (W control) 
None - 100 + 6 (20) 
Phloretin 20 ,uM 92 f 6 (8) 
50 ,uM 55 * 2 (7)* 
100 FM 16 + 1 (8)* 
200 pM 10 f 1 (7)* 
Cytochalason B 10 pg/ml 47 * 8 (4)* 
100 pg/ml 44 * 10 (4)* 
Mannoheptu- 
lose 20 mM 93 + 4 (7) 
* Significantly less than control P<O.OOl 
HIT cells were incubated in the presence of 5 mM 
glucose and the additions shown for 1 h at 37°C. Data 
are expressed relative to the mean control (no addition) 
rates of insulin release in the same experiment and are 
given as mean f SE for the number of observations 
shown 
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tulose but was markedly decreased by 50-180 PM 
phloretin or lo-100 pg/ml cytochalasin B. 
4. DISCUSSION 
In confirmation of a previous study [lo] we find 
that the uptake of sugars into HIT-T15 B-cells is 
slow, in marked contrast to normal rat or mouse 
islet cells [ 1,13,14]. Direct measurement of glucose 
in HIT cells also showed that the intracellular con- 
centration remained lower than extracellular after 
30 min incubation with 1 or 10 mM glucose [lo]. 
Thus, the transport of sugars into the cell may 
represent he rate-limiting step for their utilization. 
If this is so, then agents inhibiting glucose trans- 
port should produce parallel inhibition of glucose 
utilization by HIT cells. This prediction has been 
verified in the present study. Both phloridzin and 
its aglycone phloretin inhibit mammalian glucose 
transporters in a variety of cells including islets of 
Langerhans [ 13,15,16]. Both agents markedly de- 
pressed HIT cell glucose utilization with phloretin 
being particularly potent. This situation contrasts 
with normal islets in which inhibition of glucose 
transport by phloretin is not accompanied by im- 
paired glucose utilization because of the non-rate- 
limiting nature of sugar transport [2]. HIT cells 
glucose utilization was also inhibited by cyto- 
chalasin B which inhibits the glucose transporter in 
various tissues [ 171, including islets [ 181. Caffeine 
also inhibited HIT cell glucose utilization as pre- 
dicted from the inhibitory effect of the methyl- 
xanthine on sugar uptake in islets and other cells 
[ 141. In contrast, mannoheptulose which inhibits 
glucose phosphorylation and glucose utilization in 
normal islets [2,3] did not inhibit glucose utiliza- 
tion in HIT cells. This finding is also consistent 
with the view that in HIT cells the rate-limiting 
step for glucose metabolism is transport rather 
than phosphorylation; it may also be, however, 
that mannoheptulose is only poorly taken up by 
HIT cells. 
Some information on the characteristics of the 
HIT cell glucose transporter is afforded by the pre- 
sent study. Thus the K,,, for glucose utilization of 
4 mM reflects the affinity of the glucose trans- 
porter for the sugar. Moreover those sugars that 
reduce the rate of formation of 3Hz0 from [5-3H]- 
glucose indicate those sugars which are recognised 
by the transport system. Neither L-glucose nor N- 
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acetylglucosamine are substrates for the trans- 
porter. Galactose, 6-deoxygalactose, goldthio- 
glucose and fructose compete only weakly with 
glucose for entry. However, mannose, 3-O-methyl- 
glucose and 2-deoxyglucose are well transported as 
evidenced by the marked inhibition of glucose 
utilization. This pattern of specificity is broadly 
similar to that in normal islets except that in the 
latter there is significant uptake of N-acetylglu- 
cosamine albeit at a much slower rate than glucose 
[2,191. 
Since in the substrate-site hypothesis [2,20] there 
is close correspondence between rates of glucose 
utilization and rates of glucose-stimulated insulin 
release, the present study permitted the prediction 
that HIT cell insulin release should differ from 
that of normal islets in certain specific aspects. 
Firstly, the concentration dependence of glucose- 
stimulated insulin release should be lower than in 
normal islets, reflecting the affinity of the trans- 
port system rather than of glucokinase; this has 
already been noted [8,9]. Secondly, glucose-sti- 
mulated insulin release by HIT cells in contrast to 
that in normal islets should be inhibited by phlor- 
etin and cytochalasin B: this prediction was con- 
firmed. Thirdly, and again confirmed here, 
mannoheptulose which markedly inhibits glucose- 
stimulated insulin release from normal islets 
should not inhibit release from HIT cells. 
We conclude from these observations that the 
secretory behaviour of HIT cells is consistent with 
the substrate-site hypothesis but, in contrast with 
normal B-cells, the glucose sensor is the sugar 
transporter. 
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